4//SEC Filing
PRAECIS PHARMACEUTICALS INC 4
Accession 0001033025-05-000005
CIK 0001033025operating
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 5:23 PM ET
Size
8.7 KB
Accession
0001033025-05-000005
Insider Transaction Report
Form 4
GARNICK MARC B
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2005-05-27+100,000→ 100,000 totalExercise: $0.67From: 2006-05-27Exp: 2015-05-27→ Common Stock, par value $.01 per share (100,000 underlying)
Holdings
- 501,672
Common Stock, par value $.01 per share
- 16,288(indirect: By Trust)
Common Stock, par value $.01 per share
- 3,531(indirect: By Trust)
Common Stock, par value $.01 per share
Footnotes (3)
- [F1]Reflects distributions for no consideration to Dr. Garnick in April 2005 of 18,581 shares by the Garnick Family 1999 Grantor Retained Annuity Trust and 18,793 shares by the Garnick Family 2003 Grantor Retained Annuity Trust for the purpose of meeting the GRAT's annuity payment obligations.
- [F2]The term of the option is ten years from the date of grant.
- [F3]These options vest and become exercisable over a four-year period. Options with respect to 25% of the shares vest and become exercisable on May 27, 2006, and options with respect to the remaining shares vest and become exercisable in equal monthly installments thereafter. These options shall vest and become immediately exercisable under certain circumstances in connection with a change of control of the Company.
Documents
Issuer
PRAECIS PHARMACEUTICALS INC
CIK 0001033025
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001033025
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 5:23 PM ET
- Size
- 8.7 KB